How will you approach drug sequencing in patients with PMR given the SAPHYR data?

The SAPHYR study enrolled patients with PMR who relapsed while tapering prednisone at daily doses equal to or greater than 7.5 mg. One group of patients received sarilumab 200 mg every 2 weeks along with a 14-week prednisone taper and another group of patients received a placebo along with a 52-week...

This is a great question and one where we need more data to guide clinical practice. As with any new therapy, there will be a slow uptake in practice and we will need to learn more about the use of IL-6 inhibitors in a real-world setting. To date, IL-6 inhibitors are only being used in a minority of...